The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Company profile

REGENERON PHARMACEUTICALS, INC. insider acquisitions

Company CIK 0000872589 · Reported insider acquisitions and filing context.

Company filings at SEC ↗
REGN · Nasdaq

These are company listings. A transaction is linked to a particular security only when the filing provides enough information.

Company activity summary

By transaction date, as of October 23, 2026.

7 days30 days90 daysOverlapping periods · securities and currencies kept separate
90-day company acquisitions grouped by security, category, original code, and currency.
Type / codeReported securityTransactionsKnown purchase valueMissing amounts
Exercise / conversionCode MCommon StockNon-derivative · Currency not specified1Not applicable0

Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.MURPHY ANDREW JMURPHY ANDREW JSING GEORGE LSING GEORGE LYANCOPOULOS GEORGEYANCOPOULOS GEORGESCHLEIFER LEONARD SSCHLEIFER LEONARD SPitofsky JasonPitofsky JasonFenimore Christopher R.Fenimore Christopher R.McCourt MarionMcCourt MarionVan Plew Daniel PVan Plew Daniel PMURPHY ANDREW J · October 13, 2026 · Exercise / conversion · Common StockSING GEORGE L · December 30, 2025 · Exercise / conversion · Common StockYANCOPOULOS GEORGE · December 9, 2025 · Exercise / conversion · Common StockSCHLEIFER LEONARD S · December 9, 2025 · Exercise / conversion · Common StockPitofsky Jason · December 5, 2025 · Stock award · Non-Qualified Stock Option (right to buy)Pitofsky Jason · December 5, 2025 · Stock award · Common StockMURPHY ANDREW J · December 5, 2025 · Stock award · Non-Qualified Stock Option (right to buy)MURPHY ANDREW J · December 5, 2025 · Stock award · Common StockFenimore Christopher R. · December 5, 2025 · Stock award · Non-Qualified Stock Option (right to buy)Fenimore Christopher R. · December 5, 2025 · Stock award · Common StockMcCourt Marion · December 5, 2025 · Stock award · Non-Qualified Stock Option (right to buy)McCourt Marion · December 5, 2025 · Stock award · Common StockVan Plew Daniel P · December 5, 2025 · Stock award · Non-Qualified Stock Option (right to buy)Van Plew Daniel P · December 5, 2025 · Stock award · Common StockMURPHY ANDREW J · October 29, 2025 · Exercise / conversion · Common StockOct 29, 2025Oct 13, 2026
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

21 dated transactions · 8 of 11 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Oct 13, 2026REGENERON PHARMACEUTICALS, INC.Common StockMURPHY ANDREW JExercise / conversion
Dec 30, 2025REGENERON PHARMACEUTICALS, INC.Common StockSING GEORGE LExercise / conversion
Dec 9, 2025REGENERON PHARMACEUTICALS, INC.Common StockYANCOPOULOS GEORGEExercise / conversion
Dec 9, 2025REGENERON PHARMACEUTICALS, INC.Common StockSCHLEIFER LEONARD SExercise / conversion
Dec 5, 2025REGENERON PHARMACEUTICALS, INC.Non-Qualified Stock Option (right to buy)Pitofsky JasonStock award
Dec 5, 2025REGENERON PHARMACEUTICALS, INC.Common StockPitofsky JasonStock award
Dec 5, 2025REGENERON PHARMACEUTICALS, INC.Non-Qualified Stock Option (right to buy)MURPHY ANDREW JStock award
Dec 5, 2025REGENERON PHARMACEUTICALS, INC.Common StockMURPHY ANDREW JStock award
Dec 5, 2025REGENERON PHARMACEUTICALS, INC.Non-Qualified Stock Option (right to buy)Fenimore Christopher R.Stock award
Dec 5, 2025REGENERON PHARMACEUTICALS, INC.Common StockFenimore Christopher R.Stock award
Dec 5, 2025REGENERON PHARMACEUTICALS, INC.Non-Qualified Stock Option (right to buy)McCourt MarionStock award
Dec 5, 2025REGENERON PHARMACEUTICALS, INC.Common StockMcCourt MarionStock award
Dec 5, 2025REGENERON PHARMACEUTICALS, INC.Non-Qualified Stock Option (right to buy)Van Plew Daniel PStock award
Dec 5, 2025REGENERON PHARMACEUTICALS, INC.Common StockVan Plew Daniel PStock award
Dec 5, 2025REGENERON PHARMACEUTICALS, INC.Non-Qualified Stock Option (right to buy)LAROSA JOSEPH JStock award
Dec 5, 2025REGENERON PHARMACEUTICALS, INC.Common StockLAROSA JOSEPH JStock award
Nov 20, 2025REGENERON PHARMACEUTICALS, INC.Common StockBassler Bonnie LExercise / conversion
Nov 20, 2025REGENERON PHARMACEUTICALS, INC.Common StockLAROSA JOSEPH JExercise / conversion
Oct 29, 2025REGENERON PHARMACEUTICALS, INC.Common StockMURPHY ANDREW JExercise / conversion
Oct 30, 2025REGENERON PHARMACEUTICALS, INC.Common StockPOON CHRISTINE AExercise / conversion
Oct 29, 2025REGENERON PHARMACEUTICALS, INC.Common StockPOON CHRISTINE AExercise / conversion

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Share price & reported acquisitions

Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.

Price history is not available

Market-price history is not connected yet.

REGN · Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.

Reported acquisitions

Filing-date filters apply to the list and timeline. The summary above uses transaction dates.

Reset
Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedReporting ownersType / securityQuantityPrice / reference valueDetails
Trade:
MURPHY ANDREW JCo-Chief Scientific Officer
Exercise / conversionCommon StockNon-derivative security · Code M17,000381.92Value: 6,492,640Currency not specifiedView ↗
Trade: Exercise / conversionCommon StockNon-derivative security · Code M9,212520.01Value: 4,790,332.12Currency not specifiedView ↗
Trade:
YANCOPOULOS GEORGEBd. Co-Chair, President & CSO · Director
Exercise / conversionCommon StockNon-derivative security · Code M146,815555.67Value: 81,580,691.05Currency not specifiedView ↗
Trade:
SCHLEIFER LEONARD SBd. Co-Chair, President & CEO · Director
Exercise / conversionCommon StockNon-derivative security · Code M172,723555.67Value: 95,976,989.41Currency not specifiedView ↗
Trade:
Pitofsky JasonVP Controller
Stock awardNon-Qualified Stock Option (right to buy)Derivative security · Code A2,2610Value: 0Currency not specifiedView ↗
Trade:
Pitofsky JasonVP Controller
Stock awardCommon StockNon-derivative security · Code A2,0640Value: 0Currency not specifiedView ↗
Trade:
MURPHY ANDREW JEVP Research
Stock awardNon-Qualified Stock Option (right to buy)Derivative security · Code A18,3150Value: 0Currency not specifiedView ↗
Trade:
MURPHY ANDREW JEVP Research
Stock awardCommon StockNon-derivative security · Code A3,7150Value: 0Currency not specifiedView ↗
Trade: Stock awardNon-Qualified Stock Option (right to buy)Derivative security · Code A14,9240Value: 0Currency not specifiedView ↗
Trade: Stock awardCommon StockNon-derivative security · Code A3,0270Value: 0Currency not specifiedView ↗
Trade:
McCourt MarionEVP Commercial
Stock awardNon-Qualified Stock Option (right to buy)Derivative security · Code A12,2100Value: 0Currency not specifiedView ↗
Trade:
McCourt MarionEVP Commercial
Stock awardCommon StockNon-derivative security · Code A2,4760Value: 0Currency not specifiedView ↗
Trade:
Van Plew Daniel PEVP & General Mgr, Industrial
Stock awardNon-Qualified Stock Option (right to buy)Derivative security · Code A18,3150Value: 0Currency not specifiedView ↗
Trade:
Van Plew Daniel PEVP & General Mgr, Industrial
Stock awardCommon StockNon-derivative security · Code A3,7150Value: 0Currency not specifiedView ↗
Trade:
LAROSA JOSEPH JEVP General Counsel and Secret
Stock awardNon-Qualified Stock Option (right to buy)Derivative security · Code A12,2100Value: 0Currency not specifiedView ↗
Trade:
LAROSA JOSEPH JEVP General Counsel and Secret
Stock awardCommon StockNon-derivative security · Code A2,4760Value: 0Currency not specifiedView ↗
Trade: Exercise / conversionCommon StockNon-derivative security · Code M760371.4Value: 282,264Currency not specifiedView ↗
Trade:
LAROSA JOSEPH JEVP General Counsel and Secret
Exercise / conversionCommon StockNon-derivative security · Code M14,450555.67Value: 8,029,431.5Currency not specifiedView ↗
Trade:
MURPHY ANDREW JEVP Research
Exercise / conversionCommon StockNon-derivative security · Code M35,000555.67Value: 19,448,450Currency not specifiedView ↗
Trade: Exercise / conversionCommon StockNon-derivative security · Code M2,712520.01Value: 1,410,267.12Currency not specifiedView ↗
Trade: Exercise / conversionCommon StockNon-derivative security · Code M6,500520.01Value: 3,380,065Currency not specifiedView ↗

Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →